OXYTROL (Allergan, Inc.)
Welcome to the PulseAid listing for the OXYTROL drug offered from Allergan, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | Oxybutynin |
| SUBSTANCE NAME: | OXYBUTYNIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-02-26 |
| END MARKETING DATE: | 0000-00-00 |
OXYTROL HUMAN PRESCRIPTION DRUG Details:
| Item Description | OXYTROL from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.9(mg/d) |
| START MARKETING DATE: | 2003-02-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-6153_f36f3819-927f-4ec6-a42e-333af9a6907a |
| PRODUCT NDC: | 0023-6153 |
| APPLICATION NUMBER: | NDA021351 |
Other OXYBUTYNIN Pharmaceutical Manufacturers / Labelers:
